Brady NYSE: BRC reported what Chief Executive Officer Russell Shaller called a “fantastic quarter,” as the identification and safety products company posted record adjusted earnings per share and broad-based organic sales growth in its fiscal 2026 third quarter.
The company reported adjusted diluted earnings per share of $1.50, up 23% from $1.22 in the same quarter last year and a new quarterly record. GAAP diluted earnings per share rose to $1.21 from $1.09. Net income increased 10.6% to $57.8 million, while adjusted net income rose 22.3% to $71.9 million.
Organic sales grew 8.2% in the quarter, with total sales growth of 13.8% after including contributions from acquisitions and foreign currency translation. Chief Financial Officer Ann Thornton said the results reflected “strong organic sales growth, improved gross profit margin, efficiencies throughout SG&A, and growth in operating income throughout our global businesses.”
Get Brady alerts:
Sales Growth Led by Both Regions Brady said both of its operating regions contributed to the quarter’s organic growth. The Americas and Asia region grew organic sales 10.1%, while Europe and Australia grew 4.5% organically.
In Americas and Asia, sales reached a record $290.1 million, up 14.4% on a reported basis. Shaller said Brady grew sales in all key product lines in the region, with particular strength in wire identification. Wire ID represents 20% of revenue in Americas and Asia, and sales in that product line increased 19% during the quarter.
Shaller said data centers are making a “meaningful impact” on growth in wire identification. He also cited strong sales of portable, benchtop and automated printer units, which supported growth across wire identification, product identification and safety and facility identification.
In Europe and Australia, total sales rose 12.6% to $145.2 million, aided by an 8.1% benefit from foreign currency translation. Shaller said the region returned to growth despite a weak manufacturing environment in Europe and conflict in the Middle East. Wire ID represents 13% of sales in Europe and Australia and grew 13% in the quarter.
Margins and Cash Flow Improve Gross profit margin improved to 51.8% from 51.0% in the prior-year quarter. Thornton said the improvement reflected cost reduction actions taken last year, including the closure of manufacturing facilities in Beijing, China, and Buffalo, New York, as well as sales growth led by highly engineered products.
SG&A expense was $128.7 million, compared with $108.7 million a year earlier. As a percentage of sales, SG&A increased to 29.6% from 28.4%. Excluding amortization, acquisition-related expenses and certain prior-year reorganization costs, however, SG&A declined to 25.3% of sales from 26.5%.
Brady continued to increase research and development spending. R&D expense was $23.5 million, or 5.4% of sales, compared with $19.2 million, or 5.0% of sales, in the prior-year quarter. Thornton said printer unit sales increased nearly 8% year over year, adding that consumable revenue is expected to follow printer placements.
Operating cash flow increased 30.7% to $78.2 million, while free cash flow rose 20.8% to $67.2 million. Year to date, operating cash flow was up nearly 35%. Brady ended the quarter with a net cash position of $148.6 million, which Thornton said was more than triple the company’s net cash position a year earlier.
Guidance Raised for Fiscal 2026 Brady raised its full-year adjusted EPS guidance to a range of $5.20 to $5.30, up from its previous range of $4.95 to $5.15. The company said the new adjusted EPS outlook implies growth of 13% to 15.2% compared with fiscal 2025.
The company also updated its GAAP EPS guidance to a range of $4.66 to $4.76, compared with the prior range of $4.62 to $4.82. Brady continues to expect organic sales growth in the mid-single-digit percentage range for the fiscal year ending July 31, 2026.
Other guidance assumptions include depreciation and amortization expense of approximately $44 million, capital expenditures of approximately $45 million and a full-year income tax rate of about 21%. Thornton said potential risks include a stronger U.S. dollar, inflationary pressures the company cannot offset quickly enough and a broader slowdown in economic activity.
Honeywell PSS Acquisition in Focus Brady also discussed its previously announced agreement to acquire Honeywell’s Productivity Solutions and Services, or PSS, business. Shaller said the transaction would more than double the markets Brady can serve and add enterprise-level workforce productivity as a “critical third pillar” to the company’s customer offering.
Shaller said the combination would bring together Brady’s durable labels, printers, software and specialty adhesive materials with PSS’s mobility and scanning solutions. He said Brady intends to preserve PSS’s customer and channel partner relationships and continue investing in R&D and software offerings, including operational intelligence, voice and SwiftDecoder.
Brady said PSS sales declined by just under 2% in calendar 2025 compared with calendar 2024, then grew nearly 5% in the first quarter of calendar 2026. Shaller said Brady expects the acquired business to add approximately $0.80 of adjusted EPS accretion in the first year after closing, excluding synergies. He said the company’s best estimate for closing remains Aug. 1, pending regulatory filings and other external factors.
Thornton said Brady plans to finance the acquisition with $500 million of Term Loan A bank debt and $800 million of private placement debt, with an expected interest rate below 6%. She said the company expects net leverage of approximately 2.0 to 2.5 times at closing and expects to delever below 2 times within two years.
Executives Address Data Centers, New Printer and Board Resignations During the question-and-answer session, Shaller said data center-related demand remains a tailwind, particularly for wire identification. He said Brady is not seeing acceleration or deceleration from current trends, but views the pace of data center construction as supportive of multi-year demand rather than a short-term surge.
Asked about the i4311 portable 4-inch printer launched in February, Shaller said it is performing about 50% above the company’s normal expectations for a printer launch. He described the product as “new to the world” and said it allows users to print larger-format thermal transfer labels without returning to a printer station.
Shaller also addressed recent board resignations, saying the optics were “awful” but attributing the departures to the significantly increased time commitment required by the Honeywell transaction. He said all board members present for the acquisition vote supported the deal and that there was “no dissent.”
“We reported an excellent quarter,” Shaller said in closing, adding that Brady’s investments in R&D are paying off and that the company finished the quarter with momentum.
About Brady NYSE: BRCBrady Corporation is a global provider of identification and safety solutions, specializing in the design, manufacture and sale of products that help businesses improve safety, security and efficiency. The company offers an array of durable labels, signs, safety devices, printing systems and software platforms tailored to a wide range of industrial and commercial environments.
Founded in 1914 by William H. Brady, Brady Corporation has grown from a regional marker manufacturer into a diversified global enterprise.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Brady Right Now?Before you consider Brady, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brady wasn't on the list.
While Brady currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling around 200 points on Monday.
Following the market opening Monday, the Dow traded down 0.04% to 49,506.27 while the NASDAQ dipped 0.78% to 26,021.41. The S&P 500 also fell, dropping, 0.37% to 7,380.86.
Leading and Lagging Sectors
Energy shares jumped by 1.8% on Monday.
In trading on Monday, information technology stocks fell by 1.6%.
Top Headline
Brady Corporation (NYSE:BRC) reported upbeat first-quarter earnings on Monday before the market opened.
Brady reported adjusted earnings per share of $1.50, beating the consensus estimate of $1.34. In addition, it reported revenue of $435.23 million, beating the consensus estimate of $406.07 million, and representing a 13.8% increase year-over-year.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded up 1.4% to $106.93 while gold traded down 0.3% at $4,546.40.
Silver traded down 0.6% to $77.070 on Monday, while copper rose 0.2% to $6.3065.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.5%, while Spain's IBEX 35 Index rose 0.8%. London's FTSE 100 gained 1.3%, Germany's DAX rose 1.5%, while France's CAC 40 rose 0.4%.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 falling 0.97%, Hong Kong's Hang Seng Index dipping 1.11%, China's Shanghai Composite declining 0.09% and India's BSE Sensex gaining 0.10%
Economics
The NAHB/Wells Fargo Housing Market Index climbed to 37 in May from 34 in April. The New York Fed's Services Business Activity Index rose 8.2 points to a reading of -5.8 in May. Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Brady Corporation (BRC +2.15%) rose by almost 17% by 2 p.m today on the release of its stellar third quarter 2026 earnings report. Clearly, the company has excellent trading momentum because management raised its full-year 2026 adjusted diluted earnings per share (EPS) guidance from a range of $4.95 to $5.15 to a new range of $5.20 to $5.30 while maintaining its underlying assumptions for tax rates and depreciation and amortization expenses.
Why Brady raised guidance The reason for the guidance hike? If you don't know it, you might be able to guess it. It largely comes down to data centers. The labeling, printing, and identification (barcode and RFID) products company might seem like a strange candidate for an under-the-radar AI stock. Still, the reality is that correctly labeling critical infrastructure in data centers is essential to ensuring their ongoing operation.
Today's Change
(
2.15
%) $
1.75
Current Price
$
82.92
As CEO, Russell Shaller noted on the earnings call, wire and identification make up 20% of Brady's revenue in the Americas and Asia, and the business's sales were up 19% in the quarter, helping drive organic sales in the Americas and Asia up 10.4%. Ultimately, total company sales rose 8.2% in the quarter.
Image source: Getty Images.
Where next for Brady The excellent momentum in its core business is good news ahead of its agreed acquisition of Honeywell's Productivity Solutions and Services (PSS) business for $1.4 billion. The deal will add Brady's strength in labeling and printing to PSS's expertise in mobile computing and barcode scanners. It's an exciting move that allows Brady's management to expand its customer base, generate $25 million in annual cost synergies, and unlock the full value of a leading player in the ID market.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Brady and Honeywell International. The Motley Fool has a disclosure policy.
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Monday.
U.S. stocks settled mixed on Monday, with the S&P 500 and Nasdaq Composite falling during the session amid declines in tech stocks.
President Donald Trump struck an uncompromising tone on Iran, posting that the conflict would end only when Tehran issued "Documents of Surrender" and "admit their defeat to the great power and force of the magnificent U.S.A."
In earnings, Brady Corp. (NYSE:BRC) reported upbeat first-quarter earnings on Monday.
On the economic data front, the NAHB/Wells Fargo Housing Market Index climbed to 37 in May from 34 in April. The New York Fed’s Services Business Activity Index rose 8.2 points to a reading of -5.8 in May.
Most sectors on the S&P 500 closed on a positive note, with energy, financial and consumer staples stocks recording the biggest gains on Monday. However, information technology and industrials stocks closed the session lower.
The Dow Jones closed higher by around 160 points to 49,686.12 on Monday. The S&P 500 fell 0.07% to 7,403.05, while the Nasdaq Composite dipped 0.51% at 26,090.73 during Monday's session.
What Is CNN Business Fear & Greed Index?At a current reading of 61.8, the index remained in the “Greed” zone on Monday, versus a prior reading of 63.
The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Brady Corporation NYSE: BRC just broke out of its traditional industrial mold, fueled by capacity-constrained demand for AI data center infrastructure and a highly accretive $1.4 billion acquisition. With gross margins expanding, this under-the-radar compliance manufacturer is rapidly repricing as a premier picks-and-shovels enterprise automation play.
Brady Today
$83.06 +1.89 (+2.32%)
As of 02:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$65.76▼
$99.29Dividend Yield1.18%
P/E Ratio18.93
Price Target$103.00
For decades, the market has viewed Brady Corporation as a reliable, slow-growth dividend payer that produces industrial labels and safety signs. That narrative was shattered following an aggressive single-day stock repricing of over 18%. The primary catalyst was a massive earnings beat and a structural upward revision in full-year guidance.
Get Brady alerts:
Beneath the headline numbers, a structural shift is taking place in the physical economy. The hyper-growth in artificial intelligence relies entirely on physical data center infrastructure. Upgrading and expanding these facilities requires immense compliance efforts, including high-margin wire identification, automated tracking hardware, and safety infrastructure. Brady Corporation stands directly in the path of this capital expenditure avalanche.
Wiring the AI BoomThe company's fiscal Q3 2026 earnings report revealed exceptional fundamental momentum. Brady Corporation reported record adjusted earnings per share (EPS) of $1.50, beating the Wall Street consensus estimate of $1.35. Revenue rose 13.8% year-over-year (YOY) to $435.24 million, comfortably clearing the anticipated $406.07 million.
The regional breakdown isolates exactly where this growth originates. The Wire and Identification segment posted 19% growth in the Americas and Asia region and 13% growth in Europe. Management directly attributes this volume to data center construction. Data center integrators are currently operating at virtual capacity limits, creating a multi-year backlog for Brady Corporation's identification infrastructure. Facilities cannot come online without exhaustive cable tagging and safety tracing, making Brady Corporation products a mandatory, non-negotiable line item in server farm construction budgets.
Furthering the organic growth narrative, the newly launched i4311 portable thermal printer is currently selling 50% above internal launch projections. The i4311 targets plant safety and manufacturing professionals, allowing operators to print complex compliance tags directly on the warehouse floor. In the industrial printing space, hardware placement guarantees a recurring revenue stream of high-margin specialty adhesive labels and proprietary ink ribbons. This razor-and-blade model creates a highly sticky consumable ecosystem that generates cash flow long after the initial equipment sale.
Crucially, this demand surge comes with heavy pricing power. Brady Corporation expanded gross margins by 50 basis points YOY to 51.8%. Operating cash flow jumped 30.7% to $78.2 million. When an industrial manufacturer pushes gross margins past 50%, it signals that it provides mission-critical, highly engineered solutions rather than commoditized hardware.
Powering Up: Brady Acquires Honeywell PSSWhile organic growth accelerates, management executed a major capital allocation pivot by agreeing to acquire the Productivity Solutions and Services division from Honeywell International NASDAQ: HON for $1.4 billion.
This transaction immediately doubles the addressable market for Brady Corporation. The Productivity Solutions and Services unit generates roughly $1.1 billion in annual revenue, adding significant scale and positioning Brady Corporation in the enterprise-level workforce productivity sector. By securing established mobility computers, barcode scanners, and operational intelligence software, Brady Corporation will compete directly with legacy giants like Zebra Technologies NASDAQ: ZBRA in the automated identification and data capture market.
Financially, the deal structure protects Brady's balance sheet. Financed via a $500 million term loan and $800 million in private placement debt, Brady Corporation leverages a preexisting $148.6 million net cash position and robust free cash flow to fund the expansion. Management expects an interest rate below 6% on the debt and projects net leverage will sit around two to 2.5 times at closing. Thanks to its strong cash generation capabilities, Brady Corporation plans to deleverage quickly to below 2x within 2 years.
Management projects the acquisition will deliver 80 cents of adjusted EPS accretion in year one, before factoring in any operational savings. The market briefly misunderstood this transaction when two board members resigned earlier in the month, triggering a 10% sell-off. Management quickly clarified that the departures stemmed entirely from the severe, unexpected time commitments required to execute the complex integration, rather than internal friction. The board voted unanimously to approve the transaction, signaling total internal alignment on the strategic pivot.
Big Money Accumulates BradyOverall MarketRank™99th Percentile
The climb in Brady's stock price to above $84 was not driven by retail short-squeeze mechanics. Short interest is negligible at 1.27% of the float, or roughly 540,000 shares. The aggressive price action stems entirely from genuine institutional accumulation and a fundamental recalibration of valuation multiples. Major quantitative and index players, such as First Trust Advisors and Dimensional Fund Advisors, hold significant positions, providing a stable foundation for the stock.
Derivatives data heavily support the bullish thesis. Options trading volume and bullish call flow entirely eclipsed historical earnings-day averages for Brady Corporation. Market makers are actively pricing in a sustained volatility expansion as institutional investors digest the pivot toward AI data center infrastructure.
Insiders recognized the valuation disconnect early. During the third quarter, management repurchased 63,000 shares at an average price of $81.59 per share. This capital deployment signals strong internal conviction in Brady's intrinsic value prior to the blowout earnings release.
Fully Charged: Plugging in for the Long HaulDespite pushing higher, Brady Corporation's valuation metrics remain well-grounded. The stock trades at a trailing price-to-earnings (P/E) ratio of about 20 and a forward P/E ratio of just 17. Compared to peers in enterprise automation trading at steep growth premiums, Brady Corporation offers a highly profitable, lower-risk entry point for sector exposure.
The yield profile heavily favors long-term holders. Brady Corporation yields 1.1% and pays 98 cents annually. Backed by a 39-year consecutive track record of dividend increases, Brady Corporation holds elite status as a dividend aristocrat. The payout ratio remains highly conservative at just 23% of earnings and 14% of cash flow, leaving ample capital to service the new acquisition debt while continuing to raise the dividend.
Following the raised full-year fiscal 2026 adjusted EPS guidance to $5.20 to $5.30, Wall Street analysts are actively resetting consensus price targets to the $100 to $102 range. Investors seeking exposure to the physical buildout of AI infrastructure without paying extreme big tech multiples may want to add Brady Corporation to their watchlists. Cautious investors might prefer to wait for a broader market pullback to initiate a position, allowing the initial post-earnings volatility to settle into a new technical base.
Should You Invest $1,000 in Brady Right Now?Before you consider Brady, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brady wasn't on the list.
While Brady currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
MILWAUKEE, May 19, 2026 (GLOBE NEWSWIRE) -- On May 19, 2026, Brady Corporation’s (NYSE: BRC) Board of Directors declared a dividend to shareholders of the company’s Class A Common Stock of $0.245 per share, payable on July 31, 2026, to shareholders of record at the close of business on July 10, 2026.
Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2025, employed approximately 6,400 people in its worldwide businesses. Brady’s fiscal 2025 sales were approximately $1.51 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.
For More Information Contact:
Investor Contact: Ann Thornton (414) 438-6887
Media Contact: Kate Venne (414) 438-5176
June 08, 2026 07:00 ET | Source: Brady Corporation
Russell Shaller to Retire After an Accomplished 11-year Tenure with BradyCurrent Board Member, Vineet Nargolwala, Appointed Chief Executive Officer MILWAUKEE, June 08, 2026 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), today announced that the Board of Directors has appointed Vineet Nargolwala, an accomplished technology executive and a current member of the Company’s Board of Directors, to succeed Russell Shaller as Chief Executive Officer effective June 8, 2026. Mr. Shaller recently informed the Board of Directors of his decision to retire as both an officer and director of the Company. At the request of the Board of Directors, Mr. Shaller will remain with the Company in a consultative position until August 1, 2026, to ensure a smooth transition. Mr. Nargolwala will remain a member of the Board of Directors.
Bradley Richardson, Chair of the Board of Directors of Brady Corporation, said, “On behalf of our Board and the entire Brady team worldwide, I would like to thank Russell for his unparalleled contributions to the Company over the past eleven years. Under his leadership, the Company made strategic investments that drove market share, record-high EPS results, and strong returns to our shareholders. During his tenure as CEO, the market value of the company rose nearly 90%. We are eternally grateful to Russell, and we wish him the very best in his retirement.”
“It has been a privilege to lead the Brady Corporation team,” said Russell Shaller. “Together, we launched incredible new products, expanded our portfolio through key strategic acquisitions, and achieved five consecutive years of both organic sales growth and record EPS. I have worked closely with Vineet over the past four years, and I believe that I leave the organization in extremely capable hands. I am excited for the future of Brady as it embarks upon the next chapter of growth.”
The Board of Directors believes that Mr. Nargolwala is uniquely qualified to succeed Mr. Shaller as the Chief Executive Officer as the Company significantly expands and transforms with the announced acquisition of the Productivity Solutions and Services (“PSS”) business from Honeywell. He is a proven public company CEO with extensive experience leading growth and cultural transformations in global technology organizations with deep engineering and technology cultures.
Mr. Nargolwala previously served as President, Chief Executive Officer and Director of Allegro MicroSystems, Inc. from June 2022 to February 2025. Prior to joining Allegro, Mr. Nargolwala was with Sensata Technologies for nearly a decade. He has served on the Company’s Board of Directors for the past four years and has been intricately involved in the Board’s assessment of, and the decision to acquire, the PSS business. Earlier in his career, Mr. Nargolwala spent nearly 10 years at Honeywell in senior leadership roles.
Mr. Richardson continued, “We are exceptionally fortunate that Vineet has agreed to become the next Chief Executive Officer of Brady Corporation. He brings decades of experience in industrial technology applications, overseeing large, publicly traded organizations, nurturing culture, and driving transformation and growth. We believe that the combination of his experience on the Brady Board and his long tenure with Honeywell earlier in his career, uniquely positions him to lead our growth transformation. Vineet’s appointment as our next CEO is an important step that the Board is taking to enhance our leadership and Board composition as we transform the Company with the PSS acquisition, and we are confident in his ability to seamlessly integrate the PSS business with our existing strong Brady operations.”
Vineet Nargolwala said, “I am deeply honored to step into the role of CEO at such an important moment in our Company’s journey. Having served on the Board, I have had the privilege of seeing firsthand the talent, commitment and resilience that define this Company and underpin its strong reputation. I want to thank Russell for his leadership and contributions to position us for this exciting next chapter. I wish him and his family all the best in retirement.”
Mr. Nargolwala continued, “I could not be more excited about the opportunity that lies ahead as we prepare to close the most transformative acquisition in our company’s history. As we look to harness the tremendous potential of our complementary product lines, I am confident in this team’s ability to expand our capabilities and create even greater value for our customers, employees and shareholders.”
Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2025, employed approximately 6,400 people in its worldwide businesses. Brady’s fiscal 2025 sales were approximately $1.51 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.
In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.
The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate and grow acquired companies; difficulties in protecting our websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious break-ins; risks associated with the loss of key employees; litigation, including product liability claims; global climate change and environmental regulations; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; the possibility that events, changes or other circumstances could result in termination of the agreement to acquire the PSS business; our ability to complete the pending acquisition of the PSS business on the anticipated timeline or at all, including risks related to the timing, receipt and terms of required governmental and regulatory approvals and the satisfaction or waiver of other closing conditions; the potential effects of the pending acquisition and related integration planning on Brady’s and the PSS business’s relationships with customers, suppliers and other business partners, ability to retain, hire and integrate key personnel including officers, operating results and businesses generally; our ability to realize the anticipated strategic and financial benefits of the pending acquisition of the PSS business, including expected synergies, within the anticipated timeframe, or at all; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2025.
These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.
For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-469-2768
Sourced from organic Vietnamese coconuts, Good Nut delivers clean, refreshing hydration in three innovative flavors, including the first certified organic chocolate coconut water on the market
PHILADELPHIA--(BUSINESS WIRE)--Seven-time World Champion, entrepreneur, and philanthropist Tom Brady is bringing his relentless pursuit of peak performance to the beverage aisle. As the latest expansion of his partnership with Gopuff, the leader in instant commerce, Brady today announced the launch of Good Nut, a premium line of organic coconut water designed for those who refuse to compromise on quality or taste, available exclusively on Gopuff.
Gopuff and Tom Brady launch Good Nut, a premium line of organic coconut water designed for those who refuse to compromise on quality or taste. Now available exclusively on Gopuff.
Share “Hydration has always been a big part of my routine, and while coconut water has been a staple for me, I knew we could take it to a completely different level by teaming up with Gopuff,” said Tom Brady. “With Good Nut, we focused on keeping the ingredients simple and clean, making sure it’s exactly what I’d want in my own fridge.”
As consumers continue to seek less processed, lower-sugar beverages, the global market for coconut water is expected to reach $11 billion by 2030. This demand is also evident with Gopuff customers as coconut water sales have surged 115% year-over-year on the platform.
Capitalizing on this shift, Good Nut offers a premium alternative to over-processed sports drinks. Sourced from organic Vietnamese coconuts and with no added sugars, Good Nut delivers a clean, refreshing hydration experience in a sleek 11.8 oz can. True to Brady’s disciplined approach to nutrition, the entire line contains no added sweeteners and nothing artificial. Good Nut is available in three delicious flavors, including:
Original Coconut Water: Made from handpicked Vietnamese coconuts, refined for flavor, texture, and refreshment down to the last sip. It’s the perfect, clean coconut water. Chocolate Coconut Water: Move over, chocolate milk. Made with only three, simple ingredients, and no added sugars, Good Nut Chocolate Coconut Water is rich and creamy, even without the dairy. It’s the first and only certified organic chocolate coconut water on the market. Sparkling Coconut Water: Brighter, bubblier and refreshing in a way plain water never could be. “Good Nut started with Tom telling us about how much he loves drinking chocolate coconut water,” said Tyler Stewart, Head of Marketing at Gopuff. “We quickly realized there was an opportunity to shake up the category with a product that tastes incredible, uses great ingredients, and has a bold brand that gets people talking. Blending premium products with brands that are playful, unexpected, and don’t take themselves too seriously has become a huge part of how we build together with Tom. Whether it’s GOAT Gummies, our lobbying campaign with Super Monday Off, or now Good Nut, we’re always trying to give our customers and fans more of what they want, and of course entertain them a little along the way.”
To kick off the launch, Brady leans into Good Nut’s unconventional name with a new brand video. Throughout the video, Brady delivers a polished pitch highlighting the quality and benefits of the product, yet he consistently stops short of naming it. The punchline, of course, is the name he refuses to say: Good Nut. Watch it here!
Whether recovering from a workout or looking for a clean afternoon pick-me-up, Gopuff ensures that fans and health-conscious consumers can get Good Nut’s elite-level hydration delivered in as fast as 15 minutes. Beginning today, Good Nut is available exclusively on Gopuff for $3.29 per can, with discounted pricing of $2.96 per can available to FAM members.
Gopuff was built to bring the world’s best products to your door in minutes, but it has evolved into a platform where some of those products are born. The company has established itself as the go-to launchpad and growth engine for emerging talent-led brands, including Tom Brady’s GOAT Gummies, Selena Gomez’s co-branded Serendipity ice cream bars, Giannis Antetokounmpo's FR34K Gummies, a limited-edition Halloween chocolate bar with Alix Earle, and more. With nationwide infrastructure, control over its inventory, and a model built for speed, Gopuff connects fans with their favorite brands in minutes.
About Gopuff
Gopuff, the leader in instant commerce, offers more than 5,000 products delivered in as fast as 15 minutes. Founded in 2013 by Yakir Gola and Rafael Ilishayev, the company operates its own micro-fulfillment centers, leveraging proprietary technology and a hyper-local logistics network to offer speed, reliability, and affordability to millions of customers across the U.S. and U.K.
To learn more, visit www.gopuff.com or follow Gopuff on Facebook, X or Instagram. Download the Gopuff app on iOS and Android.
Shares in labeling, printing, and identification company Brady Corporation (BRC +2.15%) slumped by 10.4% by 1 p.m. today. The move comes as the company announced the immediate retirement of its CEO, Russell Shaller. Here's why the move matters.
Brady's CEO transition Shaller will remain in a consultative position until the start of August and will be replaced by a member of Brady's board, Vineet Nargolwala, who will remain a member of the Board as CEO.
Today's Change
(
2.15
%) $
1.75
Current Price
$
82.92
The timing of the move may concern many investors, as it comes ahead of a major strategic transformation, with the company set to acquire Honeywell's Productivity Solutions and Services (PSS) business in the second half of 2026. The acquisition will add PSS's mobile and handheld scanning devices expertise with Brady's printing and labeling strength. While some apprehension around the timing of the CEO transition is understandable, it should be noted that Nargolwala spent a large part of his career (almost a decade) at Honeywell and had other senior roles at Allegro MicroSystems and Sensata Technologies.
Image source: Getty Images.
Where next for Brady The dip looks like an attractive buying opportunity, not least because Brady offers investors the combination of an under-the--radar play on AI (labeling of data centers) and an acquisition-led growth story driven by acquiring a leading company (PSS) whose management may have been distracted by the parent company's breakup.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Brady and Honeywell International. The Motley Fool has a disclosure policy.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Considering buying BRC stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Why:Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.
So What: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next:To join the prospective class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On June 8, 2026, Investing.com published an article entitled "Ensign Group stock tumbles after short seller report." The article stated that Ensign shares fell after "short seller Hunterbrook released a report alleging the nursing home operator’s business model relies on inadequate patient care and gaming quality metrics." Further, the article stated that Hunterbrook "published findings from a five-month investigation claiming the company’s profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates. The report alleges patients have suffered and died as a result."
On this news, Ensign Group shares fell sharply in intraday trading on June 8, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608395089/en/
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON THE ENSIGN GROUP, INC. (ENSG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On June 8, 2026, investment media group Hunterbrook Media published a report entitled “Ensign: The Nursing Home Empire Built of Fatal Neglect.” The report alleges that “Ensign’s business model relies on delivering inadequate care to patients while gaming data.” The report also alleges that “former employees in different states described systematic misrepresentations.”
On this news, Ensign’s stock price fell as much as 11% during intraday trading on June 8, 2026, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Ensign securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com.
Email us at: [email protected] us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ENSIGN GROUP, INC. (ENSG), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On June 8, 2026, investment media group Hunterbrook Media published a report entitled “Ensign: The Nursing Home Empire Built of Fatal Neglect.” The report alleges that “Ensign’s business model relies on delivering inadequate care to patients while gaming data.” The report also alleges that “former employees in different states described systematic misrepresentations.”
On this news, Ensign’s stock price fell $13.88, or 8.2%, to close at $156.42 per share on June 8, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Ensign securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: [email protected],
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Boston, Massachusetts--(Newsfile Corp. - June 9, 2026) - Block & Leviton is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential securities law violations. Investors who have lost money in their The Ensign Group, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/ensg.
What is this all about?
The Ensign Group fell more than 5% in intraday trading on June 8, 2026 after Hunterbrook Media published a report alleging that Ensign's growth and profitability were driven by chronic understaffing at its nursing facilities, resulting in inadequate patient care, violations of staffing requirements, misleading quality metrics, and substantial related-party payments. The report further alleged that former employees described document falsification, improper billing practices, and efforts to manipulate performance data while the Company touted industry-leading clinical outcomes and quality ratings.
Who is eligible?
Anyone who purchased The Ensign Group, Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.
Whistleblower?
If you have non-public information about The Ensign Group, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.
Why should you contact Block & Leviton?
Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300734
Source: Block & Leviton LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Ensign (NASDAQ: ENSG). The investigation results from inaccurate statements Ensign may have made regarding its financial statements, business operations and prospects.
Click here to join our investigation or to obtain additional information, or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
On June 8, 2026, a short seller report detailed allegations that Ensign facilities were chronically understaffed in violation of various state minimum staffing laws, and that Ensign "routes taxpayer dollars to its executives and to its own affiliates."
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ENSIGN GROUP, INC. (ENSG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
What Happened?
On June 8, 2026, investment media group Hunterbrook Media published a report entitled “Ensign: The Nursing Home Empire Built of Fatal Neglect.” The report alleges that “Ensign’s business model relies on delivering inadequate care to patients while gaming data.” The report also alleges that “former employees in different states described systematic misrepresentations.”
On this news, Ensign’s stock price fell $13.88, or 8.2%, to close at $156.42 per share on June 8, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
Whistleblower Notice
Persons with non-public information regarding Ensign should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected].
About Glancy Prongay Wolke & Rotter LLP
GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm’s recent successes, GPWR was named one of Law360’s Securities Groups of the Year and ranked second-highest in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
The Ensign Group's CEO touted "record high" occupancy and improving staffing on May 1, 2026 -- weeks later, a short-seller report alleged systemic neglect and quality-measure gaming, and the stock dropped sharply.
, /PRNewswire/ -- Shareholders of The Ensign Group (NASDAQ: ENSG) who lost money after the stock dropped sharply following a short-seller report alleging systemic quality-measure gaming and improper billing practices are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
On May 1, 2026, CEO Barry Port told investors on the Q1 2026 earnings call that "85% of all of our operations are at 4- or 5-star quality measures" and that the Company was "seeing improvements in turnover, stable wage growth and reduced reliance on agency staffing even with increased occupancy." Port also stated that same-store and transitioning occupancy had reached "new record highs during the quarter of 84.3% and 85.1%, respectively." Guidance was raised on the basis of these metrics.
On June 8, 2026, Hunterbrook published a short-seller report alleging that the Company had engaged in systemic neglect, manipulated CMS star-rating quality data, and employed improper related-party billing practices -- directly contradicting the operational picture management had presented five weeks earlier. ENSG shares fell sharply on the news. The investigation is examining whether the Company's forward-looking statements regarding quality performance, occupancy levels, and staffing trends were made without adequate basis at the time they were issued.
If you purchased ENSG shares and suffered a loss, click here to discuss your rights with Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com
Frequently Asked Questions About the ENSG Investigation
Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether The Ensign Group made materially false or misleading statements regarding quality-measure performance, occupancy levels, and staffing stability. When a short-seller report contradicted those representations on June 8, 2026, the stock price declined sharply.
Q: When did The Ensign Group allegedly mislead investors?A: The investigation focuses on statements made during and around the Q1 2026 earnings call on May 1, 2026, where management presented operational metrics that were subsequently challenged by the Hunterbrook short-seller report on June 8, 2026.
Q: What do ENSG investors need to do right now?A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What if I already sold my ENSG shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ENSG and sold at a loss may still participate in the investigation.
Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions. The overwhelming majority of affected investors never appear in court.
Q: What does it cost me to participate?A: Nothing. Securities investigations are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
The Ensign Group reported 85% of facilities at 4- or 5-star quality ratings on its Q1 2026 earnings call. A short-seller report alleges those ratings were gamed -- and the stock dropped sharply.
, /PRNewswire/ -- Investors in The Ensign Group (NASDAQ: ENSG) lost significant value when shares dropped sharply after a Hunterbrook short-seller report on June 8, 2026, alleged systemic quality-measure gaming at the skilled nursing facility operator. Shareholders who lost money on ENSG are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.
On the Company's Q1 2026 earnings call on May 1, 2026, CEO Barry Port told investors: "85% of all of our operations are at 4- or 5-star quality measures." He also stated that same-store and transitioning occupancy had reached "new record highs during the quarter of 84.3% and 85.1%, respectively." On June 8, 2026, the Hunterbrook report alleged that those quality ratings had been inflated through systematic manipulation of CMS star-rating data. ENSG shares fell sharply on the news.
CMS star ratings are a primary driver of reimbursement rates and facility valuations in the skilled nursing industry. The Company presented these metrics as evidence of operational excellence and used them as the basis for raising forward guidance during the same earnings call. The Hunterbrook report's allegations that these ratings did not reflect actual care quality called those representations into question.
If you purchased The Ensign Group shares and suffered a loss, click here to discuss your legal rights. You may also reach Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.
SueWallSt -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.
Frequently Asked Questions About the ENSG Investigation
Q: Who is eligible to participate in the ENSG investigation?A: Investors who purchased ENSG stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether The Ensign Group made materially false or misleading statements regarding quality-measure performance, occupancy figures, and staffing metrics. When a short-seller report challenged those representations on June 8, 2026, the stock price declined sharply.
Q: How much did ENSG stock drop?A: Shares fell sharply after Hunterbrook published a report alleging systemic quality-measure gaming, neglect, and improper billing practices at The Ensign Group's facilities.
Q: What do ENSG investors need to do right now?A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible to participate in the investigation.
Q: What if I already sold my ENSG shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ENSG and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate?A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
New York, New York--(Newsfile Corp. - June 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into The Ensign Group, Inc. ("The Ensign Group, Inc.") (NASDAQ: ENSG) concerning potential violations of the federal securities laws.
The Hunterbrook report alleged that ENSG inflated CMS star ratings -- a key metric that drives reimbursement rates and investor confidence. On the Company's Q1 2026 earnings call on May 1, 2026, CEO Barry Port stated that "85% of all of our operations are at 4- or 5-star quality measures." The short-seller report directly challenged the accuracy of those quality metrics, alleging that the ratings were the product of systematic data manipulation rather than genuine clinical performance.
The report also alleged improper related-party billing practices at the company's network of skilled nursing facilities. Prior to the report's publication, on June 2, 2026, a director filed a Form 144 attesting that "he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The stock declined sharply in the session following the Hunterbrook publication.
If you suffered a loss on your The Ensign Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (212)363-7500
Fax: (212)363-7171
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300878
SAN DIEGO, June 10, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether The Ensign Group, Inc. (NASDAQ: ENSG) or certain of its executive officers violated state or federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
What if I purchased Ensign securities?
If you purchased Ensign securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation.
Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
There is no cost or obligation to you.
Background of the Investigation
On June 8, 2026, Hunterbrook Media published a report concerning The Ensign Group, Inc. The report alleged, among other things, that Ensign’s growth and profitability were driven by chronic understaffing at its nursing facilities, resulting in inadequate patient care, violations of staffing requirements, misleading quality metrics, and substantial related-party payments.
Hunterbrook further alleged that Ensign’s facilities reported superior quality metrics while allegedly performing worse on independently verifiable measures. The report also alleged that former employees described document falsification, improper billing practices, efforts to manipulate performance data, and other practices that allegedly conflicted with the Company’s public statements regarding its clinical outcomes and quality ratings.
Following publication of the Hunterbrook report, Ensign’s stock price declined in intraday trading.
In light of these allegations, Johnson Fistel is investigating whether Ensign complied with federal laws. If you suffered losses, or are a long-term holder of Ensign stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Top Law Firm – Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder litigation involving securities fraud, breaches of fiduciary duties, and other violations of state and federal law.
Johnson Fistel has been recognized as one of the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. In 2024, the firm recovered approximately $90,725,000 for investors.
Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. This press release may be considered a promotional communication. The attorney responsible for this communication is Frank J. Johnson.
Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations
(619) 814-4471 [email protected]
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Ensign Group, Inc. (“Ensign” or “the Company”) (NASDAQ: ENSG) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ensign is the subject of a report published by Hunterbrook Media that alleges its profitability depends on understaffing at nursing facilities, which in turn resulted in poor patient care, violations of staffing requirements, and other negative impacts. The report also claims that former employees say the Company manipulated performance data.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Ensign Group, Inc. (“Ensign” or “the Company”) (NASDAQ: ENSG) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ensign is the subject of a report published by Hunterbrook Media that alleges its profitability depends on understaffing at nursing facilities, which in turn resulted in poor patient care, violations of staffing requirements, and other negative impacts. The report also claims that former employees say the Company manipulated performance data.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260610103274/en/
Key Takeaways Ensign benefits from rising occupancy, patient volumes and strong post-acute care demand.ENSG added five operations, signed deals for 17 more and posted strong occupancy gains.Standard Bearer rental revenues rose 27.1% as owned real estate assets reached 160. The Ensign Group, Inc. (ENSG - Free Report) remains well positioned to benefit from favorable demographic and post-acute care trends, supported by rising occupancy and patient volumes. Headquartered in San Juan Capistrano, CA, the company operates through its Skilled Services and Standard Bearer segments.
Following recent acquisitions, Ensign's portfolio has expanded to approximately 396 healthcare operations, including 48 senior living operations, across 17 states. It holds a market capitalization of around $9.14 billion. ENSG has risen 3.9% over the past year compared with the industry’s average gain of 4.1%. ENSG currently holds a Zacks Rank #3 (Hold).
Where Do Estimates for ENSG Stand?The Zacks Consensus Estimate for Ensign Group’s 2026 earnings is pegged at $7.48 per share, indicating a 13.9% year-over-year rise. The consensus mark for revenues is pegged at $5.82 billion for 2026, implying 15% year-over-year growth. It beat earnings estimates in each of the past four quarters, with an average surprise of 3.4%.
The Ensign Group, Inc. Price, Consensus and EPS Surprise
The Ensign Group, Inc. price-consensus-eps-surprise-chart | The Ensign Group, Inc. Quote
ENSG’s Growth DriversEnsign continues to benefit from robust demand for post-acute care services, translating into higher patient volumes and occupancy gains. In the first quarter of 2026, same-store occupancy improved 190 basis points year over year to 84.3%, while transitioning-facility occupancy increased 310 basis points to 85.1%. Skilled revenues and skilled patient days at transitioning operations rose 9.6% and 8.5%, respectively, reflecting strong underlying demand and successful operational integration.
Strategic acquisitions remain a core growth pillar for Ensign. The company added five stand-alone skilled nursing operations in the first quarter of 2026 and signed agreements for 17 additional facilities. Its proven ability to integrate acquisitions, improve clinical performance and strengthen referral relationships supports higher occupancy, patient volumes and earnings growth. Ensign's ROIC of 8.1% significantly exceeds the industry average of 3.1%, highlighting the effectiveness of its growth strategy and capital allocation.
Beyond operating skilled nursing facilities, Ensign continues to expand its real estate portfolio through its Standard Bearer segment. As of March 31, 2026, the company owned 160 real estate assets, providing greater control over occupancy costs and creating an additional stream of rental income primarily from its own operating subsidiaries. During the first quarter of 2026, Standard Bearer rental revenues increased 27.1% year over year to $36.1 million, while segment income rose 25.9%. ENSG's strategy of pairing healthcare operations with selective real estate ownership strengthens cash-flow generation enhances returns on acquisitions, and provides another powerful avenue for long-term earnings growth.
Ensign's balance sheet remains a competitive advantage. The company ended the first quarter of 2026 with $539.5 million in cash and cash equivalents against only $136.5 million in long-term debt. It had approximately $592 million of available borrowing capacity under its revolving credit facility. Strong operating cash flow of $100.2 million provides ample flexibility to fund acquisitions, invest in existing operations and pursue real estate purchases without materially increasing leverage. Additionally, $20 million remained available under its share repurchase authorization as of March 31, 2026. Reflecting its conservative financial profile, total debt represented just 5.6% of capital, substantially below the industry average of 89.3%.
ENSG: Risks to WatchThere are some factors, however, that investors should keep a careful eye on.
Ensign remains exposed to reimbursement uncertainty, as Medicare and Medicaid accounted for 69.1% of service revenues in the first quarter of 2026. Consequently, changes in reimbursement rates, regulatory policies or payer reviews could adversely impact profitability. Competition for acquisitions, labor and patient referrals remains intense across the fragmented post-acute care industry. Heightened competitive pressures could increase operating costs, raise acquisition multiples and constrain occupancy growth.
Ensign has experienced steady cost inflation in recent years, driven primarily by higher service and rent expenses. Total expenses increased 12.3% in 2024 and 18.7% in 2025, followed by an 18.0% year-over-year rise to $1.26 billion in the first quarter of 2026. If expense growth continues to outpace revenue gains, it could pressure margins and limit earnings growth.
Stocks to ConsiderSome better-ranked stocks in the broader Medical space are Indivior Pharmaceuticals, Inc. (INDV - Free Report) , Centene Corporation (CNC - Free Report) and BrightSpring Health Services, Inc. (BTSG - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Indivior Pharmaceuticals’ 2026 earnings is pegged at $4.05 per share, indicating a 62% year-over-year improvement. INDV beat earnings estimates in each of the trailing four quarters, with the average surprise being 65.44%. The consensus estimate for 2026 revenues is pinned at $1.26 billion, implying 1.5% year-over-year growth.
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.47 per share, indicating 66.8% year-over-year growth. It has witnessed nine upward revisions in the past 60 days, with no movement in the opposite direction. CNC beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 74.9%. The consensus estimate for 2026 revenues is pinned at $191.03 billion.
The Zacks Consensus Estimate for BrightSpring Health’s 2026 earnings is pegged at $1.67 per share, which has witnessed five upward revisions in the past 60 days, with no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 14.6%. The consensus estimate for 2026 revenues is pinned at $15.05 billion, implying 16.6% year-over-year growth.
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.
So What: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On June 8, 2026, Investing.com published an article entitled "Ensign Group stock tumbles after short seller report." The article stated that Ensign shares fell after "short seller Hunterbrook released a report alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics." Further, the article stated that Hunterbrook "published findings from a five-month investigation claiming the company's profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates. The report alleges patients have suffered and died as a result."
On this news, Ensign Group shares fell sharply in intraday trading on June 8, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
The Ensign Group lost significant market value after a short-seller report alleged systemic quality-measure gaming and improper billing practices at the skilled nursing facility operator.
NEW YORK--(BUSINESS WIRE)--Shares of The Ensign Group (NASDAQ: ENSG) dropped sharply on June 8, 2026, after Hunterbrook Media published a short-seller report alleging systemic neglect, quality-measure gaming, and improper related-party billing across the company's skilled nursing facilities. Shareholders who lost money on ENSG are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
The sell-off came after the Hunterbrook report directly challenged claims made by CEO Barry Port on the Q1 2026 earnings call on May 1, 2026. On that call, Port stated that "85% of all of our operations are at 4- or 5-star quality measures" and that same-store occupancy had reached "new record highs during the quarter of 84.3% and 85.1%, respectively." The short-seller report alleged those quality ratings were gamed and that staffing levels were mischaracterized.
The market reaction was immediate. ENSG shares fell on heavy volume following the report's publication, erasing weeks of post-earnings gains in a single session. Prior to the report, ENSG had traded near its highs on the strength of the Q1 2026 results and raised guidance.
If you purchased The Ensign Group shares and suffered a loss, click here to get more information about the investigation. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities investigations and actions. Ranked in ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the ENSG Investigation
Q: Who is eligible to participate in the ENSG investigation? A: Investors who purchased ENSG stock and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether The Ensign Group made materially false or misleading statements regarding the quality of its skilled nursing operations, occupancy metrics, and staffing stability. When the Hunterbrook short-seller report challenged those claims, the stock price declined sharply.
Q: What do ENSG investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential recovery.
Q: What if I already sold my ENSG shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ENSG and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: Nothing. Securities investigations are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Boston, Massachusetts--(Newsfile Corp. - June 11, 2026) - Block & Leviton is investigating The Ensign Group, Inc. (Nasdaq: ENSG) for potential securities law violations. Investors who have lost money in their The Ensign Group, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/ensg.
What is this all about?
The Ensign Group fell more than 5% in intraday trading on June 8, 2026 after Hunterbrook Media published a report alleging that Ensign's growth and profitability were driven by chronic understaffing at its nursing facilities, resulting in inadequate patient care, violations of staffing requirements, misleading quality metrics, and substantial related-party payments. The report further alleged that former employees described document falsification, improper billing practices, and efforts to manipulate performance data while the Company touted industry-leading clinical outcomes and quality ratings.
Who is eligible?
Anyone who purchased The Ensign Group, Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.
Whistleblower?
If you have non-public information about The Ensign Group, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.
Why should you contact Block & Leviton?
Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301155
Source: Block & Leviton LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON THE ENSIGN GROUP, INC. (ENSG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On June 8, 2026, investment media group Hunterbrook Media published a report entitled “Ensign: The Nursing Home Empire Built of Fatal Neglect.” The report alleges that “Ensign’s business model relies on delivering inadequate care to patients while gaming data.” The report also alleges that “former employees in different states described systematic misrepresentations.”
On this news, Ensign’s stock price fell $13.88, or 8.2%, to close at $156.42 per share on June 8, 2026, thereby injuring investors.
Then, on June 11, 2026, Muddy Waters published a research report on Ensign, describing how, among other things the Company “engages in a systematic scheme at an estimated ~20 of Skilled Nursing Facilities (SNFs) to rent the licenses of Administrators who are not generally present at, nor actually managing, the facilities.”
On this news, Ensign’s stock price fell as much as 6.6% during intraday trading on June 11, 2026, thereby injuring investors further.
Contact Us To Participate or Learn More:
If you purchased Ensign securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Email us at: [email protected]
Visit our website at: www.frankcruzlaw.com.
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On June 8, 2026, Investing.com published an article entitled "Ensign Group stock tumbles after short seller report." The article stated that Ensign shares fell after "short seller Hunterbrook released a report alleging the nursing home operator’s business model relies on inadequate patient care and gaming quality metrics." Further, the article stated that Hunterbrook "published findings from a five-month investigation claiming the company’s profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates. The report alleges patients have suffered and died as a result."
On this news, Ensign Group shares fell sharply in intraday trading on June 8, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
A short-seller report alleged that The Ensign Group gamed CMS quality ratings and engaged in improper billing practices -- and the stock dropped sharply on the news. June 12, 2026 09:38 ET | Source: Levi & Korsinsky, LLP
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Shares of The Ensign Group (NASDAQ: ENSG) fell sharply on June 8, 2026, after Hunterbrook published a short-seller report alleging systemic quality-measure gaming, neglect, and improper related-party billing at the skilled nursing facility operator. Investors who lost money on ENSG are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
The Hunterbrook report alleged that ENSG inflated CMS star ratings -- a key metric that drives reimbursement rates and investor confidence. On the Company's Q1 2026 earnings call on May 1, 2026, CEO Barry Port stated that "85% of all of our operations are at 4- or 5-star quality measures." The short-seller report directly challenged the accuracy of those quality metrics, alleging that the ratings were the product of systematic data manipulation rather than genuine clinical performance.
The report also alleged improper related-party billing practices at the company's network of skilled nursing facilities. Prior to the report's publication, on June 2, 2026, a director filed a Form 144 attesting that "he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The stock declined sharply in the session following the Hunterbrook publication.
Shareholders who suffered losses on their Ensign Group investment may click here to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.
Frequently Asked Questions About the ENSG Investigation
Q: Who is conducting the ENSG investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased ENSG securities and suffered losses. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether The Ensign Group made materially false or misleading statements regarding its quality-measure performance, staffing metrics, and billing practices. When the Hunterbrook short-seller report challenged those representations, the stock price declined sharply.
Q: What do ENSG investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What if I already sold my ENSG shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ENSG and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: Nothing. Securities investigations are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ENSIGN GROUP, INC. (ENSG), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by em.
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1) while repurchasing millions of dollars’ worth of ChampionX Corporation (“ChampionX” or the “Company”) common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited (“SLB”) to acquire ChampionX at a premium to prevailing market prices;
(2) Defendants failed to either abstain from trading or disclose SLB’s offer(s), which, if disclosed, would have signaled to investors that ChampionX’s stock was worth significantly more than its trading price;
(3) Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and
(4) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all sellers of ChampionX Corporation (NASDAQ: CHX) common stock between February 29, 2024 and April 1, 2024. ChampionX is a global provider of chemistry solutions, artificial lift systems, and highly engineered equipment and technologies for the drilling and production of oil and gas.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is the class period? February 29, 2024 – April 1, 2024
What are the allegations? Robbins LLP is Investigating Allegations that ChampionX Corporation (CHX) Repurchased Shares of its Stock in Violation of Securities Laws
According to the complaint, during the class period, defendants repurchased 216,000 shares of ChampionX stock – worth millions of dollars – from unsuspecting investors without disclosing material nonpublic information about SLB’s offers to purchase ChampionX at a premium to then-current prices. If this information had been disclosed as required it would have indicated to investors that ChampionX’s stock was worth significantly more.
Plaintiff alleges that when investors learned the truth that SLB was willing to buy all the Company's outstanding stock for a significant premium above the trading price, ChampionX's stock price climbed sharply, harming investors who sold during the class period.
What can shareholders do now? You may be eligible to participate in the class action against ChampionX Corporation. Shareholders who wish to serve as lead plaintiff for the class must submit their papers with the court by July 14, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against ChampionX Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
New York, New York--(Newsfile Corp. - June 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300174
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
New York, New York--(Newsfile Corp. - June 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300430
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
New York, New York--(Newsfile Corp. - June 7, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
while repurchasing millions of dollars' worth of ChampionX Corporation ("ChampionX" or the "Company") common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited ("SLB") to acquire ChampionX at a premium to prevailing market prices; Defendants failed to either abstain from trading or disclose SLB's offer(s), which, if disclosed, would have signaled to investors that ChampionX's stock was worth significantly more than its trading price; Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CHX, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297974
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
New York, New York--(Newsfile Corp. - June 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300473
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1)while repurchasing millions of dollars’ worth of ChampionX Corporation (“ChampionX” or the “Company”) common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited (“SLB”) to acquire ChampionX at a premium to prevailing market prices; (2)Defendants failed to either abstain from trading or disclose SLB’s offer(s), which, if disclosed, would have signaled to investors that ChampionX’s stock was worth significantly more than its trading price; (3)Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and (4)as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - June 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300670
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether ChampionX and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until July 14, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired ChampionX securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
A Complaint has filed on behalf of investors who sold ChampionX common stock during the Class Period, alleging that the defendants failed to disclose material information, which artificially deflated the price of ChampionX common stock.
Per the allegations of the Complaint, on February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The ChampionX class action lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors.
During the Class Period, ChampionX’s average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the “Class Period”), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX’s average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
New York, New York--(Newsfile Corp. - June 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300800
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Philadelphia, Pennsylvania--(Newsfile Corp. - June 10, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ChampionX Corporation (NASDAQ: CHX) ("ChampionX" or the "Company") on behalf of investors who sold ChampionX common stock during the period from February 29, 2024 through April 1, 2024 (the "Class Period").
Investor Deadline: Investors who sold ChampionX common stock during the Class Period may, no later than July 14, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.
Prior to its acquisition by SLB in July 2025, ChampionX, headquartered in The Woodlands, TX, was a provider of chemistry solutions and technologies serving the global oil and gas sector.
The Complaint alleges that throughout the Class Period, ChampionX purchased Company shares at artificially depressed prices due to material non-public information. Specifically, defendants allegedly failed to disclose that: (i) ChampionX had received an unsolicited, non-public acquisition offer from SLB; (ii) ChampionX had an obligation to either disclose the offer or abstain from repurchasing its shares; and (iii) while those offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by SLB.
On February 29, 2024, ChampionX received an unsolicited, non-public offer from SLB to acquire all outstanding shares at $36.70 per share. On March 7, 2024, SLB raised its offer to $37.80 per share. During the Class Period, ChampionX's average stock price was $33.32 per share - significantly below the undisclosed offer prices.
On April 2, 2024, during pre-market hours, ChampionX disclosed the merger with SLB. The merger eventually closed on July 16, 2025, with SLB acquiring ChampionX for $40.58 per share.
If you are a ChampionX investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267) 764-4865.
About Berger Montague
Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300842
Source: Berger Montague
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ChampionX Corporation (“ChampionX” or the “Company”) (formerly NASDAQ:CHX) investors of the July 14, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
Should You Join The ChampionX Class Action Lawsuit:
Do you, or did you, own shares of ChampionX Corporation (formerly NASDAQ: CHX)?Did you sell your shares between February 29, 2024 and April 1, 2024, inclusive?Did you lose money in your investment in ChampionX Corporation? Investors are encouraged to act promptly and submit a form at ChampionX Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
If you wish to serve as lead plaintiff for the Class, you must file papers by July 14, 2026. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About The Lawsuit:
A lawsuit was filed on behalf of investors (the “Class”) who sold the common stock of ChampionX between February 29, 2024 and April 1, 2024, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.
The lawsuit alleges that defendants repurchased millions of dollars’ worth of ChampionX shares without disclosing material nonpublic information about Schlumberger Limited’s offers to purchase ChampionX at a premium to then-current prices, which, if disclosed as required, would have indicated to investors that ChampionX’s stock was worth significantly more.
About Bernstein Liebhard:
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
New York, New York--(Newsfile Corp. - June 10, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
while repurchasing millions of dollars' worth of ChampionX Corporation ("ChampionX" or the "Company") common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited ("SLB") to acquire ChampionX at a premium to prevailing market prices; Defendants failed to either abstain from trading or disclose SLB's offer(s), which, if disclosed, would have signaled to investors that ChampionX's stock was worth significantly more than its trading price; Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CHX, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297975
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In ChampionX (CHX) To Contact Him Directly To Discuss Their Options
If you sold common stock of ChampionX between February 29, 2024 and April 1, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ:CHX) in the United States District Court for the Southern District of New York on behalf of all persons and entities who sold common stock of ChampionX between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”).Investors have until July 14, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Allegation Details:
According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share. Next Steps:
If you purchased or otherwise acquired ChampionX shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,
derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1)while repurchasing millions of dollars’ worth of ChampionX Corporation (“ChampionX” or the “Company”) common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited (“SLB”) to acquire ChampionX at a premium to prevailing market prices; (2)Defendants failed to either abstain from trading or disclose SLB’s offer(s), which, if disclosed, would have signaled to investors that ChampionX’s stock was worth significantly more than its trading price; (3)Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and (4)as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - June 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301232
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
New York, New York--(Newsfile Corp. - June 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
while repurchasing millions of dollars' worth of ChampionX Corporation ("ChampionX" or the "Company") common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited ("SLB") to acquire ChampionX at a premium to prevailing market prices; Defendants failed to either abstain from trading or disclose SLB's offer(s), which, if disclosed, would have signaled to investors that ChampionX's stock was worth significantly more than its trading price; Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CHX, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297976
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. Esco Technologies (ESE - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Esco Technologies is a member of the Business Services sector. This group includes 238 individual stocks and currently holds a Zacks Sector Rank of #13. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Esco Technologies is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ESE's full-year earnings has moved 6% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ESE has gained about 42.1% so far this year. Meanwhile, stocks in the Business Services group have lost about 12.4% on average. As we can see, Esco Technologies is performing better than its sector in the calendar year.
Urgent.ly Inc. is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 83.7%.
For Urgent.ly Inc., the consensus EPS estimate for the current year has increased 3.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Esco Technologies belongs to the Technology Services industry, which includes 109 individual stocks and currently sits at #175 in the Zacks Industry Rank. On average, stocks in this group have lost 14.5% this year, meaning that ESE is performing better in terms of year-to-date returns. Urgent.ly Inc. is also part of the same industry.
Going forward, investors interested in Business Services stocks should continue to pay close attention to Esco Technologies and Urgent.ly Inc. as they could maintain their solid performance.
